000			01546 a2200433 4500
005			20250516115853.0
264		0	_c20130325
008			201303s 0 0 eng d
022			_a1471-230X
024	7		_a10.1186/1471-230X-12-152 _2doi
040			_aNLM _beng _cNLM
100	1		_aNann, Dominik
245	0	0	_aAnalysis of the clinical relevance of antimitochondrial antibodies to the β- and γ-subunits of the F1F0-ATPase in patients with primary biliary cirrhosis. _h[electronic resource]
260			_bBMC gastroenterology _cOct 2012
300			_a152 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAge of Onset
650	0	4	_aAutoantibodies _xblood
650	0	4	_aCholagogues and Choleretics _xtherapeutic use
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aLiver Cirrhosis, Biliary _xdrug therapy
650	0	4	_aLiver Transplantation
650	0	4	_aLongitudinal Studies
650	0	4	_aMale
650	0	4	_aMethotrexate _xtherapeutic use
650	0	4	_aMiddle Aged
650	0	4	_aMitochondria, Liver _ximmunology
650	0	4	_aProton-Translocating ATPases _ximmunology
650	0	4	_aTreatment Outcome
650	0	4	_aUrsodeoxycholic Acid _xtherapeutic use
650	0	4	_aYoung Adult
700	1		_aBerg, Christoph P
700	1		_aPreuss, Beate E
700	1		_aKlein, Reinhild
773	0		_tBMC gastroenterology _gvol. 12 _gp. 152
856	4	0	_uhttps://doi.org/10.1186/1471-230X-12-152 _zAvailable from publisher's website
999			_c22210326 _d22210326